The following highlights spotlight the latest research in rheumatology, featuring studies presented at this year’s annual European Alliance of Associations for Rheumatology (EULAR) 2024 Congress.
AB1693-PARE THE EVOLVING ROLE OF PATIENTS AS AUTHORS AT THE ANNUAL EUROPEAN CONGRESS OF RHEUMATOLOGY
Background: An increasing number of congresses are encouraging patients (inclusive of caregivers and patient organisation representatives) to present and publish research [1]. The European Alliance of ...
🚀Join us on the EULAR webinar with Congress: "What makes a successful EULAR 2026 Abstract? Insights from the Scientific Programme Chair" and gain practical tips on how to craft a compelling abstract, ...
🔔 The EULAR 2025 Scientific Programme is now available! Explore a diverse array of sessions covering the broad spectrum of rheumatic diseases, including state-of-the-art lectures, basic science and ...
– RESET-RA is the first randomized, sham-controlled, double-blind trial to positively demonstrate the clinical potential of neuroimmune modulation for the treatment of rheumatoid arthritis (RA) – – ...
Andrew Cope | Panel member for Basic and Translational Science at EULAR; Head of the Centre for Rheumatic Diseases and Associate Director of the King’s Clinical Trials Unit, King’s College London, UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results